Thursday, 15 October 2026European Markets
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document

AI Is Insatiable

View original at spectrum.ieee.org
IEEE Spectrum - Technical Title: AI Is Insatiable Date: 2026-04-06 14:22 Source: https://spectrum.ieee.org/high-bandwidth-memory-shortage <img src="https://spectrum.ieee.org/media-library/robot-hand-catching-falling-computer-chips-from-an-open-snack-bag-in-pop-art-style.png?id=65425799&width=1200&height=800&coordinates…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • If any of the big three HBM companies—Micron, Samsung, and SK Hynix—say that they are adjusting the schedule of the arrival of new production, that'd be an important signal

    60% confidence
  • Startups developing all sorts of products might pivot toward creative redesigns that use less memory

    60% confidence
  • Data centers might steer toward hardware that sacrifices some performance for less memory as adaptation to shortage

    60% confidence
  • Makers of AI processors, notably Nvidia and AMD, are demanding more and more memory for each of their chips, driven by needs of firms like Google, Microsoft, OpenAI, and Anthropic

    60% confidence
  • AI electricity consumption could account for up to 12 percent of all U.S. power by 2028

    60% confidence
  • AI hyperscalers' ravenous appetite for memory is causing current DRAM shortage, particularly for high bandwidth memory (HBM), which is a major constraint on the speed at which large language models run

    60% confidence
  • Water consumption for cooling AI data centers is predicted to double or even quadruple by 2028 compared to 2023

    60% confidence
  • If any of the big three HBM companies—Micron, Samsung, and SK Hynix—say that they are adjusting the schedule of the arrival of new production, that'd be an important signal

    60% confidence
  • AI electricity consumption could account for up to 12 percent of all U.S. power by 2028

    60% confidence
  • Constraints like shortages can lead to interesting technology solutions

    60% confidence
  • Data centers might steer toward hardware that sacrifices some performance for less memory, and startups might pivot toward creative redesigns that use less memory as constraints lead to interesting technology solutions

    60% confidence
  • Generative AI queries consumed 15 terawatt-hours in 2025 and are projected to consume 347 TWh by 2030

    60% confidence
  • AI hyperscalers' ravenous appetite for memory is a major constraint on the speed at which large language models run

    60% confidence
  • Water consumption for cooling AI data centers is predicted to double or even quadruple by 2028 compared to 2023

    60% confidence
  • Generative AI queries consumed 15 terawatt-hours in 2025 and are projected to consume 347 TWh by 2030

    60% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,377 source documents archived
Query this data → isubstrate.com